SOLID BIOSCIENCES INC's ticker is SLDB and the CUSIP is 83422E105. A total of 77 filers reported holding SOLID BIOSCIENCES INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $56,000 | -45.1% | 46,700 | -19.8% | 0.00% | – |
| Q4 2021 | $102,000 | -26.6% | 58,200 | 0.0% | 0.00% | – |
| Q3 2021 | $139,000 | -34.7% | 58,200 | 0.0% | 0.00% | – |
| Q2 2021 | $213,000 | +4.4% | 58,200 | +58.2% | 0.00% | – |
| Q1 2021 | $204,000 | -36.1% | 36,800 | -12.6% | 0.00% | – |
| Q4 2020 | $319,000 | +182.3% | 42,100 | -24.7% | 0.00% | – |
| Q3 2020 | $113,000 | -40.5% | 55,900 | -13.9% | 0.00% | – |
| Q2 2020 | $190,000 | +45.0% | 64,900 | +18.0% | 0.00% | – |
| Q1 2020 | $131,000 | -41.8% | 55,000 | +8.7% | 0.00% | – |
| Q4 2019 | $225,000 | -57.0% | 50,600 | 0.0% | 0.00% | – |
| Q3 2019 | $523,000 | +110.9% | 50,600 | +17.4% | 0.00% | – |
| Q2 2019 | $248,000 | -21.0% | 43,100 | +26.4% | 0.00% | – |
| Q1 2019 | $314,000 | -46.8% | 34,100 | +55.0% | 0.00% | – |
| Q4 2018 | $590,000 | -43.2% | 22,000 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $1,038,000 | +67.4% | 22,000 | +26.4% | 0.00% | – |
| Q2 2018 | $620,000 | – | 17,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,871,164 | $17,227,000 | 2.57% |
| RA Capital Management | 4,571,164 | $20,342,000 | 0.62% |
| Artal Group S.A. | 1,800,000 | $8,010,000 | 0.31% |
| Boxer Capital, LLC | 1,031,872 | $4,592,000 | 0.26% |
| Burrage Capital Management LLC | 80,487 | $358,000 | 0.24% |
| Ikarian Capital, LLC | 305,600 | $1,360,000 | 0.22% |
| Matisse Capital | 52,900 | $235,000 | 0.17% |
| Leap Investments LP | 49,762 | $221,000 | 0.10% |
| Spark Investment Management LLC | 138,800 | $617,000 | 0.07% |
| Alambic Investment Management, L.P. | 17,454 | $78,000 | 0.06% |